|
EP0969865B1
(en)
*
|
1996-05-23 |
2006-12-06 |
The Scripps Research Institute |
Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
AU765085B2
(en)
|
1998-05-11 |
2003-09-11 |
Miltenyi Biotec Gmbh |
Method of direct selection of antigen-specific T cells
|
|
US6230662B1
(en)
|
1998-06-22 |
2001-05-15 |
Theresa Miale |
Animal lift and transport apparatus and method for using the same
|
|
JP2002522067A
(ja)
*
|
1998-08-10 |
2002-07-23 |
カイロン コーポレイション |
一群の抗原を発現する操作された抗原提示細胞およびその使用
|
|
CA2345277C
(en)
*
|
1998-10-20 |
2011-05-24 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
US6225443B1
(en)
*
|
1999-05-19 |
2001-05-01 |
Wisconsin Alumni Research Foundation |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
|
|
US7521202B2
(en)
|
1999-12-17 |
2009-04-21 |
The Board Of Regents Of The University Of Oklahoma |
Method and apparatus for the production of soluble MHC antigens and uses thereof
|
|
DE10009341A1
(de)
*
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
WO2001080833A1
(en)
*
|
2000-04-20 |
2001-11-01 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
DE60138922D1
(de)
|
2000-10-10 |
2009-07-16 |
Univ Oklahoma |
Vergleichende ligandenabbildung aus mhc-positiven zellen
|
|
US20070026433A1
(en)
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002056908A2
(en)
*
|
2001-01-16 |
2002-07-25 |
Hildebrand William H |
Artificial antigen-presenting cells
|
|
WO2002079396A2
(en)
*
|
2001-02-13 |
2002-10-10 |
Mosca Joseph D |
Biological carriers for induction of immune responses
|
|
CA2438754C
(en)
*
|
2001-02-20 |
2014-10-07 |
Ortho-Mcneil Pharmaceutical, Inc. |
A cell therapy method for the treatment of tumors
|
|
US20040071671A1
(en)
*
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
FR2824567B1
(fr)
*
|
2001-05-11 |
2003-08-08 |
Inst Nat Sante Rech Med |
Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
|
|
US7745140B2
(en)
*
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US7638325B2
(en)
*
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
US7638326B2
(en)
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
EP1808200A3
(en)
|
2002-10-11 |
2007-09-19 |
Sentoclone AB |
Cancer immuno-therapy
|
|
US20040072262A1
(en)
*
|
2002-10-11 |
2004-04-15 |
Montero-Julian Felix A. |
Methods and systems for detecting MHC class I binding peptides
|
|
US7435592B2
(en)
|
2003-05-13 |
2008-10-14 |
Immunovative Therapies, Ltd. |
Compositions for allogeneic cell therapy
|
|
US20050095655A1
(en)
*
|
2003-11-03 |
2005-05-05 |
Montero-Julian Felix A. |
Solution-based methods for detecting MHC-binding peptides
|
|
US7592431B2
(en)
|
2004-02-26 |
2009-09-22 |
Immunovative Therapies, Ltd. |
Biodegradable T-cell Activation device
|
|
JP2007525225A
(ja)
|
2004-02-26 |
2007-09-06 |
イミュノバティブ セラピーズ， リミテッド |
細胞治療のためのｔ細胞を調製するための方法
|
|
WO2005111624A2
(en)
*
|
2004-05-07 |
2005-11-24 |
Beckman Coulter, Inc. |
Mhc bridging system for detecting ctl-mediated lysis of antigen presenting cells
|
|
EP3363907A1
(en)
|
2004-05-27 |
2018-08-22 |
The Trustees of the University of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
US7678379B2
(en)
*
|
2004-06-17 |
2010-03-16 |
Beckman Coulter, Inc. |
Mycobacterium tuberculosis epitopes and methods of use thereof
|
|
EP1712615A1
(en)
*
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
NZ590308A
(en)
|
2005-06-08 |
2012-02-24 |
Dana Farber Cancer Inst Inc |
Methods and compositions for the treatment of cancer by inhibiting the programmed cell death 1 (pd-1) pathway
|
|
WO2006138449A2
(en)
*
|
2005-06-16 |
2006-12-28 |
The Wistar Institute |
Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen
|
|
CA2634169C
(en)
|
2005-12-21 |
2012-11-27 |
Sentoclone Ab |
Method for treating disseminated cancer
|
|
WO2007071410A1
(en)
|
2005-12-21 |
2007-06-28 |
Sentoclone Ab |
Method for treating urinary bladder cancer
|
|
US8206702B2
(en)
|
2005-12-21 |
2012-06-26 |
Sentoclone International Ab |
Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer
|
|
US8211424B2
(en)
|
2005-12-21 |
2012-07-03 |
Sentoclone International Ab |
Method for treating malignant melanoma
|
|
CA2643337C
(en)
*
|
2006-03-01 |
2016-01-12 |
Janssen Pharmaceutica N.V. |
Cancer treatment combining lymphodepleting agent with ctls and cytokines
|
|
CA2665568C
(en)
*
|
2006-10-04 |
2018-01-09 |
Janssen Pharmaceutica, N.V. |
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
|
|
NZ600281A
(en)
*
|
2006-12-27 |
2013-03-28 |
Harvard College |
Compositions and methods for the treatment of infections and tumors
|
|
US20110092961A1
(en)
*
|
2008-08-13 |
2011-04-21 |
Searete Llc |
Artificial cells
|
|
SI2370593T1
(sl)
*
|
2008-11-28 |
2016-08-31 |
Emory University |
Postopek za določanje učinkovitosti antagonista pd-1
|
|
US8075895B2
(en)
*
|
2009-09-22 |
2011-12-13 |
Janssen Pharmaceutica N.V. |
Identification of antigenic peptides from multiple myeloma cells
|
|
EP2404618A1
(en)
|
2010-07-07 |
2012-01-11 |
Stichting Katholieke Universiteit meer in het bijzonder Radboud Universiteit Nijmegen |
Immunomodulatory protein constructs with a helical polymeric backbone.
|
|
NZ603641A
(en)
*
|
2010-08-06 |
2014-11-28 |
Canine Lab Inc |
Immunological function enhancing agent
|
|
CN109876138A
(zh)
|
2011-05-03 |
2019-06-14 |
免疫创新治疗有限公司 |
利用免疫疗法诱导il-12
|
|
US10350242B2
(en)
|
2011-05-03 |
2019-07-16 |
Immunovative Therapies Ltd. |
Methods for handling biological drugs containing living cells
|
|
US9260696B2
(en)
|
2012-04-24 |
2016-02-16 |
Dan S. Kaufman |
Method for developing natural killer cells from stem cells
|
|
KR102238226B1
(ko)
|
2013-05-14 |
2021-04-09 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
가공된 키메라 항원 수용체 (ｃａｒ) ｔ-세포의 인간 적용
|
|
US20160312242A1
(en)
|
2013-12-16 |
2016-10-27 |
The United States of America, as represented by the Secretary, Dep. of Health and Human Services |
Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
|
|
AU2015218239B2
(en)
|
2014-02-14 |
2019-01-31 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors and methods of making
|
|
WO2015148960A1
(en)
|
2014-03-28 |
2015-10-01 |
The Board Of Regents Of The University Of Oklahoma |
Compositions comprising soluble hla/m. tuberculosis-specific ligand complexes and methods of production and use thereof
|
|
EP3134437A1
(en)
|
2014-04-23 |
2017-03-01 |
Board of Regents, The University of Texas System |
Chimeric antigen receptors (car) for use in therapy and methods for making the same
|
|
WO2015164740A1
(en)
|
2014-04-24 |
2015-10-29 |
Board Of Regents, The University Of Texas System |
Application of induced pluripotent stem cells to generate adoptive cell therapy products
|
|
WO2016073629A1
(en)
|
2014-11-05 |
2016-05-12 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
CN107207615A
(zh)
|
2014-11-05 |
2017-09-26 |
得克萨斯州大学系统董事会 |
基因修饰的免疫效应细胞和用于扩增免疫效应细胞的工程化细胞
|
|
FR3031519B1
(fr)
|
2015-01-14 |
2016-12-30 |
Arkema France |
Composition a base de terpolymere electroactif
|
|
SG11201707540QA
(en)
*
|
2015-03-16 |
2017-10-30 |
Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft |
Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell library
|
|
EP3368075B1
(en)
|
2015-10-27 |
2020-01-29 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
CN110191898B
(zh)
|
2016-06-08 |
2024-05-10 |
英特瑞克斯顿股份有限公司 |
Cd33特异性嵌合抗原受体
|
|
JP7062640B2
(ja)
|
2016-07-29 |
2022-05-06 |
ジュノー セラピューティクス インコーポレイテッド |
抗ｃｄ１９抗体に対する抗イディオタイプ抗体
|
|
CA3043356A1
(en)
|
2016-11-09 |
2018-05-17 |
Musc Foundation For Research Development |
Cd38-nad+ regulated metabolic axis in anti-tumor immunotherapy
|
|
CN118406655A
(zh)
|
2017-01-10 |
2024-07-30 |
普瑞赛格恩公司 |
通过新基因开关表达系统调节多肽的表达
|
|
US11285196B2
(en)
|
2017-03-13 |
2022-03-29 |
Eslam Abbas Baseuny |
Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
|
|
WO2018195175A1
(en)
|
2017-04-18 |
2018-10-25 |
FUJIFILM Cellular Dynamics, Inc. |
Antigen-specific immune effector cells
|
|
CN110997920A
(zh)
|
2017-06-07 |
2020-04-10 |
英特拉克森公司 |
新型细胞标签的表达
|
|
CN119930795A
(zh)
|
2017-10-12 |
2025-05-06 |
得克萨斯大学体系董事会 |
用于免疫疗法的t细胞受体
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|
|
EA202191463A1
(ru)
|
2018-11-28 |
2021-10-13 |
Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем |
Мультиплексное редактирование генома иммунных клеток для повышения функциональности и устойчивости к подавляющей среде
|
|
US20220033778A1
(en)
|
2018-11-29 |
2022-02-03 |
Board Of Regents, The University Of Texas System |
Methods for ex vivo expansion of natural killer cells and use thereof
|
|
CN115052973B
(zh)
|
2019-11-06 |
2025-07-01 |
贝勒医学院 |
用于产生细胞毒性效应子记忆t细胞以用于癌症的t细胞治疗的方法
|
|
US20230079539A1
(en)
|
2020-02-10 |
2023-03-16 |
Board Of Regents, The University Of Texas System |
Methods for rapid cloning and expression of hla class i cells
|
|
CA3179599A1
(en)
|
2020-05-27 |
2021-12-02 |
Marco ALESSANDRINI |
Adapter molecules to re-direct car t cells to an antigen of interest
|
|
EP4267605A2
(en)
|
2020-12-23 |
2023-11-01 |
Janssen Biotech, Inc. |
Neoantigen peptide mimics
|
|
US20250235478A1
(en)
|
2022-04-28 |
2025-07-24 |
Musc Foundation For Research Development |
Chimeric antigen receptor modified regulatory t cells for treating cancer
|